MétaCan
Menu
← Back to cohort

The safety of seasonal influenza vaccination among patients prescribed immune checkpoint inhibitors: A self-controlled case series study using administrative data.

2023· article· en· W4379282018 on OpenAlexafffund
Alicia A. Grima, Jeff Kwong, Lucie Richard, Jacques Raphael, Nicole E. Basta, Alex Carignan, Karin Top, Nicholas Brousseau, Phillip Blanchette, Maria E. Sundaram

Bibliographic record

VenueJournal of Clinical Oncology · 2023
Typearticle
Languageen
FieldMedicine
TopicCancer Immunotherapy and Biomarkers
Canadian institutionsUniversité LavalUniversité de SherbrookeMcGill UniversityWestern UniversityPublic Health OntarioDalhousie UniversityUniversity of Toronto
FundersCanadian Immunization Research Network
KeywordsMedicineVaccinationPoisson regressionAdverse effectIncidence (geometry)Rate ratioInfluenza vaccineSeasonal influenzaPopulationInternal medicineImmunologyConfidence intervalEnvironmental healthDiseaseCoronavirus disease 2019 (COVID-19)

Abstract

fetched live from OpenAlex

6606 Background: Immune checkpoint inhibitor (ICI) therapy for cancer patients carries a risk of severe immune-related adverse events (IRAEs). Since vaccines are immunomodulatory, administering seasonal influenza vaccinations to individuals on ICI therapy may exacerbate this risk. However, these vaccines provide substantial benefit to this at-risk population. As severe IRAEs are rare, previous vaccine safety studies in this population have been underpowered and have shown conflicting results. Methods: We used health administration data on adult Ontarians who initiated ICI therapy and received an influenza vaccine between January 1, 2012, and December 31, 2019. We conducted a self-controlled case series study, with a pre-vaccine control period (12-weeks post-ICI initiation to 14 days before vaccine), risk period (42 days post-vaccine), and a post-vaccine control period (until observation end). Each individual contributed a maximum of 2 years of person-time. Emergency department (ED) visit(s) and/or hospitalization for any cause was used as a surrogate measure of severe IRAE frequency. We fitted a fixed effect Poisson regression model incorporating seasonality and time to estimate incidence. Results: We identified 1133 patients who received an influenza vaccine on ICI therapy. The majority were aged ≥66 years (72.7%), male (62.8%), and had lung cancer (53.9%). A quarter (25.9%) experienced an ED visit and/or hospitalization during the observation period. The rate of ED visits and/or hospitalization per person-days in the risk and control periods were similar, with an incidence rate ratio of 1.04 (95% CI: 0.75, 1.45). Subgroup and sensitivity analyses revealed similar findings. Conclusions: Receipt of a seasonal influenza vaccine was not associated with an increased incidence of ED visit or hospitalization among adults on ICI therapy. The results from this analysis suggest no significant safety concern with administering influenza vaccines to this patient population.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.006
metaresearch head score (Gemma)0.012
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.011
Threshold uncertainty score0.032

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0060.012
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.002
Bibliometrics0.0020.002
Science and technology studies0.0010.001
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.150
GPT teacher head0.473
Teacher spread0.324 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Clinical Oncology→Same topicCancer Immunotherapy and Biomarkers→French-language works237,207→